JBT Marel Reports Strong Q1 Turnaround, Swings to Profit and Reaffirms Full-Year Guidance
summarizeSummary
JBT Marel reported a strong Q1 2026, swinging to a net profit of $45 million from a significant loss in the prior year, driven by operational improvements and deleveraging, while reaffirming its full-year guidance.
check_boxKey Events
-
Significant Q1 Financial Turnaround
The company reported a net income of $45 million for Q1 2026, a substantial improvement from a net loss of $173 million in Q1 2025. GAAP diluted EPS was $0.86, up from a loss of $3.35 per share year-over-year.
-
Strong Operational Performance
Orders exceeded $1 billion for the second consecutive quarter, reaching $1.07 billion, resulting in a book-to-bill ratio of 1.14x. Revenue increased 10% year-over-year to $936 million.
-
Improved Financial Health
JBT Marel generated $119 million in operating cash flow and $100 million in free cash flow. The company also reduced its net debt to trailing twelve months adjusted EBITDA to 2.6x, indicating successful deleveraging.
-
Full-Year Guidance Reiterated
The company reaffirmed its full-year 2026 guidance, expecting consolidated revenue growth of 5-7% and adjusted EPS in the range of $8.00 to $8.50, signaling confidence in its strategic outlook.
auto_awesomeAnalysis
JBT Marel Corporation reported a significant financial turnaround in its first quarter 2026 results, swinging to a net income of $45 million compared to a net loss of $173 million in the prior year's quarter. This improvement, driven by lower non-recurring and transaction-related costs, margin enhancement efforts, and reduced interest expense, directly addresses the challenges highlighted in the 2025 annual report following the Marel acquisition. The company also demonstrated strong operational performance with orders exceeding $1 billion for the second consecutive quarter and a 10% increase in revenue. Furthermore, JBT Marel improved its balance sheet by deleveraging to 2.6x net debt to trailing twelve months adjusted EBITDA and generating $100 million in free cash flow. The reiteration of full-year 2026 guidance, including revenue growth of 5-7% and adjusted EPS of $8.00-$8.50, reinforces confidence in the company's continued recovery and strategic execution.
At the time of this filing, JBTM was trading at $121.26 on NYSE in the Technology sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $99.84 to $170.19. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.